Cell & Gene Therapy Europe

09/20/2017 - 09/21/2017
Berlin, Germany

Dr. Nicole Faust, Chief Scientific Officer at CEVEC, will be a panelist and presenter during the following sessions:

  • Panelist: „Upscaling and optimising viral vector production platforms to meet future ATMP industry demand: Part 1 – AAV“ – Track 3 on September 20 at 12:30 p.m.
  • Presenter: “CAP-GT: a scalable production platform for lentiviral and AAV gene therapy vectors” – Track 3 of the ‘Vector business & innovation‘ session on September 20 at 2:35 p.m.

Visit CEVEC at Booth # 18.

13th PEACe Conference

09/24/2017 - 09/28/2017
Valencia, Spain

Listen to the talk of Dr. Nikola Strempel, Head Cell Line Development at CEVEC:

„CAP-Go.2 cell line: Improved O-glycosylation for significantly prolonged plasma half-life of human recombinant C1 Inhibitor“

on Wednesday, September 27 at 09:30 a.m.

ESGCT 25th Anniversary Congress

10/17/2017 - 10/20/2017
Berlin, Germany

The 25th Anniversary Congress of the ESGCT will take place in Berlin, Germany, at the bcc Berlin, in collaboration with the German Society for Gene Therapy DG-GT.

Visit CEVEC at Booth # 20.

BIO-Europe 2017

11/06/2017 - 11/08/2017
Berlin, Germany

Visit CEVEC at Booth # 2.

Cell & Gene Therapy World

01/22/2018 - 01/25/2018
Miami, USA

Visit CEVEC at Booth # 707.